Insider · CIK 0001406834

Kendall Keith J

Reports to the SEC for 2 companies · WARREN, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001406834

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-06-14	FEMYFEMASYS INC · Stock Option (Right to Buy)A Award	Director	AAward	+17K sh	—	—	17,000
2022-03-10	AQSTAquestive Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director, CEO and President	AAward	+375K sh	—	—	375,000
2021-08-26	AQSTAquestive Therapeutics, Inc.G Gift	Director, CEO and President	GGift	−1,000 sh	—	—	636,149
2021-08-26	AQSTAquestive Therapeutics, Inc.G Gift	Director, CEO and President	GGift	+1,000 sh	—	—	1,000
2021-03-11	AQSTAquestive Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director, CEO and President	AAward	+250K sh	—	—	250,000
2020-12-30	AQSTAquestive Therapeutics, Inc.G Gift	Director, CEO and President	GGift	−1,000 sh	—	—	638,149
2020-12-30	AQSTAquestive Therapeutics, Inc.G Gift	Director, CEO and President	GGift	+1,000 sh	—	—	1,000
2020-12-30	AQSTAquestive Therapeutics, Inc.G Gift	Director, CEO and President	GGift	−1,000 sh	—	—	637,149
2020-12-30	AQSTAquestive Therapeutics, Inc.G Gift	Director, CEO and President	GGift	+1,000 sh	—	—	1,000
2020-06-30	AQSTAquestive Therapeutics, Inc.M Exercise/Conversion	Director, CEO and President	MExercise/Conversion	+333 sh	—	—	639,297
2020-06-30	AQSTAquestive Therapeutics, Inc.F Tax Payment	Director, CEO and President	FTax Payment	−148 sh	$4.86	−$719.28	639,149
2020-06-30	AQSTAquestive Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO and President	MExercise/Conversion	−333 sh	—	—	0
2020-06-04	AQSTAquestive Therapeutics, Inc.S Sale	Director, CEO and President	SSale	−50K sh	$5.11	−$255K	638,964
2020-05-31	AQSTAquestive Therapeutics, Inc.M Exercise/Conversion	Director, CEO and President	MExercise/Conversion	+14.6K sh	—	—	695,456
2020-05-31	AQSTAquestive Therapeutics, Inc.F Tax Payment	Director, CEO and President	FTax Payment	−6,492 sh	$4.87	−$31.6K	688,964
2020-05-31	AQSTAquestive Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO and President	MExercise/Conversion	−14.6K sh	—	—	0
2020-03-31	AQSTAquestive Therapeutics, Inc.M Exercise/Conversion	Director, CEO and President	MExercise/Conversion	+329 sh	—	—	680,983
2020-03-31	AQSTAquestive Therapeutics, Inc.F Tax Payment	Director, CEO and President	FTax Payment	−99 sh	$2.19	−$216.81	680,884
2020-03-31	AQSTAquestive Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO and President	MExercise/Conversion	−329 sh	—	—	333
2020-03-16	AQSTAquestive Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director, CEO and President	AAward	+225K sh	—	—	225,000
2020-02-29	AQSTAquestive Therapeutics, Inc.M Exercise/Conversion	Director, CEO and President	MExercise/Conversion	+14.6K sh	—	—	685,383
2020-02-29	AQSTAquestive Therapeutics, Inc.F Tax Payment	Director, CEO and President	FTax Payment	−4,729 sh	$3.73	−$17.6K	680,654
2020-02-29	AQSTAquestive Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO and President	MExercise/Conversion	−14.6K sh	—	—	14,572
2019-12-31	AQSTAquestive Therapeutics, Inc.M Exercise/Conversion	Director, CEO and President	MExercise/Conversion	+329 sh	—	—	662,985
2019-12-31	AQSTAquestive Therapeutics, Inc.F Tax Payment	Director, CEO and President	FTax Payment	−329 sh	$5.82	−$1,914.78	662,656
2019-12-31	AQSTAquestive Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO and President	MExercise/Conversion	−329 sh	—	—	662
2019-12-31	AQSTAquestive Therapeutics, Inc.F Tax Payment	Director, CEO and President	FTax Payment	−149 sh	$5.82	−$867.18	670,811
2019-11-30	AQSTAquestive Therapeutics, Inc.F Tax Payment	Director, CEO and President	FTax Payment	−6,597 sh	$7.79	−$51.4K	670,631
2019-11-30	AQSTAquestive Therapeutics, Inc.M Exercise/Conversion	Director, CEO and President	MExercise/Conversion	+14.6K sh	—	—	677,228
2019-11-30	AQSTAquestive Therapeutics, Inc.F Tax Payment	Director, CEO and President	FTax Payment	−14.6K sh	$7.79	−$114K	662,656
2019-11-30	AQSTAquestive Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO and President	MExercise/Conversion	−14.6K sh	—	—	29,144
2019-09-30	AQSTAquestive Therapeutics, Inc.M Exercise/Conversion	Director, CEO and President	MExercise/Conversion	+329 sh	—	—	662,806
2019-09-30	AQSTAquestive Therapeutics, Inc.F Tax Payment	Director, CEO and President	FTax Payment	−150 sh	$3.18	−$477	662,656
2019-09-30	AQSTAquestive Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO and President	MExercise/Conversion	−329 sh	—	—	991
2019-08-31	AQSTAquestive Therapeutics, Inc.M Exercise/Conversion	Director, CEO and President	MExercise/Conversion	+14.6K sh	—	—	669,153
2019-08-31	AQSTAquestive Therapeutics, Inc.F Tax Payment	Director, CEO and President	FTax Payment	−6,676 sh	$3.80	−$25.4K	662,477
2019-08-31	AQSTAquestive Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO and President	MExercise/Conversion	−14.6K sh	—	—	43,716
2019-08-14	AQSTAquestive Therapeutics, Inc.P Purchase	Director, CEO and President	PPurchase	+1,000 sh	$3.70	+$3,697	653,581
2019-08-14	AQSTAquestive Therapeutics, Inc.P Purchase	Director, CEO and President	PPurchase	+1,000 sh	$3.65	+$3,650	654,581
2019-08-13	AQSTAquestive Therapeutics, Inc.P Purchase	Director, CEO and President	PPurchase	+1,000 sh	$4.04	+$4,045	652,581
2019-08-09	AQSTAquestive Therapeutics, Inc.P Purchase	Director, CEO and President	PPurchase	+2,000 sh	$3.84	+$7,680	648,581
2019-08-09	AQSTAquestive Therapeutics, Inc.P Purchase	Director, CEO and President	PPurchase	+1,000 sh	$3.92	+$3,925	649,581
2019-08-09	AQSTAquestive Therapeutics, Inc.P Purchase	Director, CEO and President	PPurchase	+2,000 sh	$4.00	+$7,990	651,581
2019-06-30	AQSTAquestive Therapeutics, Inc.M Exercise/Conversion	Director, CEO and President	MExercise/Conversion	+329 sh	—	—	646,735
2019-06-30	AQSTAquestive Therapeutics, Inc.F Tax Payment	Director, CEO and President	FTax Payment	−154 sh	$4.20	−$646.8	646,581
2019-06-30	AQSTAquestive Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO and President	MExercise/Conversion	−329 sh	—	—	1,320
2019-05-31	AQSTAquestive Therapeutics, Inc.M Exercise/Conversion	Director, CEO and President	MExercise/Conversion	+14.6K sh	—	—	653,186
2019-05-31	AQSTAquestive Therapeutics, Inc.F Tax Payment	Director, CEO and President	FTax Payment	−6,780 sh	$3.72	−$25.2K	646,406
2019-05-31	AQSTAquestive Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO and President	MExercise/Conversion	−14.6K sh	—	—	58,288
2019-03-31	AQSTAquestive Therapeutics, Inc.M Exercise/Conversion	Director, CEO and President	MExercise/Conversion	+329 sh	—	—	638,877

Recent filings

Accepted (ET)
Jun 164
Kendall Keith J0001140361-23-030281
SEC(opens sec.gov)
Mar 144
Kendall Keith J0001214659-22-003894
SEC(opens sec.gov)
Aug 274
Kendall Keith J0001214659-21-009051
SEC(opens sec.gov)
Mar 154
Kendall Keith J0001214659-21-003150
SEC(opens sec.gov)
Jan 44
Kendall Keith J0001214659-21-000034
SEC(opens sec.gov)
Jul 24
Kendall Keith J0001214659-20-006104
SEC(opens sec.gov)
Jun 54
Kendall Keith J0001214659-20-005427
SEC(opens sec.gov)
Jun 24
Kendall Keith J0001214659-20-005338
SEC(opens sec.gov)
Apr 24
Kendall Keith J0001214659-20-003146
SEC(opens sec.gov)
Mar 184
Kendall Keith J0001214659-20-002749
SEC(opens sec.gov)

Companies

Address

C/O AQUESTIVE THERAPEUTICS, INC. 30 TECHNOLOGY DRIVE

WARREN, NJ, 07059